MD Fellows: Burroughs-Wellcome Fund Career Awards, internal deadline Aug. 31

The Burroughs-Wellcome Fund’s Career Awards for Medical Scientists provides up to $700,000 in support over five years to help physician-scientists bridge their advanced postdoctoral/fellowship training with the early years of faculty service. Proposals must be in the area of basic biomedical, disease-oriented, translational, or molecular, genetic, or pharmacological epidemiology research. Proposals in the area of epidemiology should contact the Fund to determine their eligibility. This bridging award is meant to facilitate the transition to a career in research and buy time from service commitments. Nominations from candidates who work in reproductive science are encouraged.

Candidates must hold an M.D., D.D.S., or D.V.M. degree and be a fellow, resident, or a postdoctoral researcher and have at least two years of postdoctoral research experience at the time of application. Proposals must be in the area of basic biomedical, disease-oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are ineligible.

Limited Submission: OHSU may nominate five candidates. If you are interested in applying, please submit a brief research summary, CV, and letter of support via the limited submission form by August 31, 2012. The external deadline for the final application to the Burroughs-Wellcome Fund is October 1, 2012.

Questions? Feel free to contact

Take a look at this week’s other Funding Opportunities.

Bookmark and Share

Comments are closed.

About the Author

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.